Latest Genetic Engineering Jobs

Director, AI/ML MIDD Oncology Clinical Pharmacology, Modeling and Simulation

Leads model-informed drug development for oncology programmes, defining and executing model-based strategies from late candidate selection through life cycle management. Conducts population PK, exposure-response and simulation-based trial design work, applying AI/ML, quantitative systems pharmacology and model-based meta-analysis to small molecules, biologics and antibody drug conjugates. Presents and defends modelling outcomes to governance boards and regulators, and contributes to protocols, analysis plans and submissions.

GSK Wavre, Belgium €119,250 – €198,750 pa

Hybrid

Director, AI/ML MIDD Oncology Clinical Pharmacology, Modeling and Simulation

Leads model-informed drug development for oncology programmes, defining and executing model-based strategies from late candidate selection through life cycle management. Conducts population PK, exposure-response and simulation-based trial design work across small molecules, biologics and antibody drug conjugates, applying AI/ML and quantitative systems pharmacology methods. Presents and defends modelling outcomes to governance boards and regulators, and contributes to protocols, analysis plans and submissions.

GSK USA - Pennsylvania - Upper Providence US$188,100 – US$313,500 pa

Hybrid

(Fixed Term) Laboratory Technician, Clinical Biomarker Laboratory, Immunoassay

Supports immunoassay development, qualification and validation, and tests clinical samples to deliver high-quality data for trials across multiple therapeutic areas. Day-to-day work includes preparing reagents and media, running assays, maintaining batch records and equipment, and authoring or reviewing SOPs and bioanalytical plans. At least 85% of time is spent in the lab, reporting to the Associate Director, Immunoassay UK.

Moderna Clinical Development

On-site Contract Clearance Required

Senior Research Associate, Bioanalytical & Molecular Assays

Perform bioanalytical assays using molecular and cellular techniques such as ddPCR, qPCR, RT-qPCR and gel electrophoresis to quantify RNA in biological matrices. Support phase-appropriate assay development, qualification and validation within a GCLP-compliant clinical framework, partnering with internal and external labs and contributing to SOPs, critical reagents and digital/automation improvements.

Moderna Clinical Development

Hybrid Permanent

Medical Director, Oncology Clinical Development - Lung & Head/Neck Cancers

Serves as the physician within oncology clinical programme teams for lung and head/neck cancers, leading medical monitoring, safety oversight and clinical data interpretation. Partners with the Senior Scientist and cross-functional teams on protocol development, regulatory interactions and investigator engagement, with on-site presence 2-3 days per week.

GSK Zug, Switzerland US$222,750 – US$371,250 pa

On-site

Medical Director, Oncology Clinical Development - Lung & Head/Neck Cancers

Serves as the physician within oncology clinical programme teams for lung and head/neck cancers, leading medical monitoring, safety oversight and clinical data interpretation across Phase I–III studies. Partners with Senior Scientists and cross-functional matrix teams on protocol development, regulatory interactions and investigator engagement, with on-site presence 2–3 days per week.

GSK London US$222,750 – US$371,250 pa

On-site

Medical Director, Oncology Clinical Development - Lung & Head/Neck Cancers

Serves as the physician within oncology clinical programme teams, leading medical monitoring and safety oversight for lung and head/neck cancer studies. Interprets clinical and safety data, contributes to protocol development, and engages investigators, regulators and cross-functional matrix teams across Phase I–III development.

GSK Mississauga, Canada US$222,750 – US$371,250 pa

On-site

Senior Medical Director, Oncology Clinical Development - GU

Leads clinical development of oncology assets in genitourinary cancers, overseeing Phase 1-3 interventional trials from protocol design through final study report. Provides real-time medical monitoring, safety review with pharmacovigilance, and regulatory document authoring, while building relationships with key external experts. Serves as a core member of the Clinical Matrix Team and contributes to disease area strategy and business development diligence.

GSK London US$284,250 – US$473,750 pa

On-site

Senior Medical Director, Oncology Clinical Development - GU

Leads clinical development of GU oncology assets, designing and executing Phase 1-3 interventional trials and serving as a core member of the Clinical Matrix Team. Provides real-time medical monitoring, safety review with pharmacovigilance, and authors clinical study reports and regulatory responses. Builds relationships with key external experts and represents the company at advisory boards and medical meetings.

GSK Waltham, United States US$284,250 – US$473,750 pa

On-site

Senior Medical Director, Oncology Clinical Development - GU

Leads clinical development of GU oncology assets, designing and executing Phase 1-3 interventional trials and serving as a core member of the Clinical Matrix Team. Provides real-time medical monitoring, safety review with pharmacovigilance, and authors clinical study reports and regulatory responses. Builds external expert relationships and represents the company at advisory boards and medical meetings.

GSK Stevenage US$284,250 – US$473,750 pa

On-site

Senior Medical Director, Oncology Clinical Development - GU

Leads clinical development for GU oncology assets, designing and executing Phase 1-3 interventional trials and serving as a core member of the Clinical Matrix Team. Provides real-time medical monitoring, safety review with pharmacovigilance, and authors clinical study reports and regulatory responses. Builds external expert relationships and represents the company at advisory boards and medical meetings.

GSK Zug, Switzerland US$284,250 – US$473,750 pa

On-site

Executive Medical Director, Clinical Development Lead - Oncology GU

Owns the clinical strategy, scientific narrative and benefit-risk framework for a genitourinary oncology asset across its lifecycle, acting as the senior clinical authority within the Medicine Development Team core quad. Directs study-level delivery through Senior Scientists, leads governance and Health Authority interactions, and applies AI-enabled analytics to sharpen development decisions. Also mentors clinical development talent and shapes standards across Oncology Clinical Development.

GSK Mississauga, Canada US$284,250 – US$473,750 pa

Hybrid

Executive Medical Director, Clinical Development Lead - Oncology GU

Owns the clinical strategy, scientific narrative and benefit-risk framework for genitourinary oncology assets, acting as the senior clinical authority on the Medicine Development Team core quad. Sets asset-level evidence-generation and governance strategy while Senior Scientists lead operational study delivery, and represents Clinical Development in health authority, advisory board and alliance interactions. Distinct for its enterprise-level scope, AI-enabled decision-making and people leadership across the oncology portfolio.

GSK London

Hybrid

Executive Medical Director, Clinical Development Lead - Oncology GU

Enterprise-level clinical strategy leader for a genitourinary oncology asset, owning the clinical roadmap, benefit-risk framework and scientific narrative across the lifecycle. Acts as the clinical authority on the Medicine Development Team core quad, representing Clinical Development in governance, health authority interactions and alliance partnerships, while directing Senior Scientists who handle study-level delivery. Distinct for its heavy emphasis on AI-enabled insights, advanced analytics and decision velocity.

GSK Warsaw, Poland PLN 593,250 – PLN 988,750 pa

Hybrid

Clinical Development Medical Director- Hepatology

Leads clinical development strategy for hepatology assets within GSK's Respiratory, Immunology & Inflammation Research Unit, from target identification through proof-of-concept studies. Accountable for clinical matrix team leadership, protocol design, medical monitoring and regulatory interactions across all development phases. Hybrid role with at least two on-site days weekly.

GSK London US$202,500 – US$371,250 pa

Hybrid